Guide

Esketamine: REMS, observed dosing time, and the billing that funds it

Summary

Offering esketamine commits a solo practice to three things at once: enrollment in the drug's FDA-mandated REMS program, a room and staff time for supervised in-office dosing with post-administration monitoring, and a billing model that pays for both the observation visit and the drug itself. The clinical fit matters less than whether your schedule, space, and cash flow can absorb an observed-dosing service that a video visit can never replace.

By Gale Editorial · Updated 2026-07-26. Every figure cited to a dated source. How we write.

What the esketamine REMS requires before you dose

Esketamine is dispensed only through an FDA-mandated REMS — a Risk Evaluation and Mitigation Strategy that gates who may prescribe it, which pharmacies may dispense it, and how each dose is given 1Ref 1U.S. Food and Drug Administration (2026).Risk Evaluation and Mitigation Strategies (REMS).That esketamine is dispensed under an FDA-mandated REMS imposing prescriber and pharmacy certification, in-office supervised administration, and a defined post-dose monitoring period.. Before you treat a single patient, you and any dispensing pharmacy must be certified in the program, and every patient is enrolled individually. The REMS is the practice you are actually opening, not the prescription pad.

The certification has three moving parts:

The prescriber and the setting. You enroll as a certified prescriber, and your site is certified to administer the drug under direct supervision 1Ref 1U.S. Food and Drug Administration (2026).Risk Evaluation and Mitigation Strategies (REMS).That esketamine is dispensed under an FDA-mandated REMS imposing prescriber and pharmacy certification, in-office supervised administration, and a defined post-dose monitoring period..
The pharmacy. Only a REMS-certified pharmacy may dispense the product, and it ships to your certified setting rather than to the patient 1Ref 1U.S. Food and Drug Administration (2026).Risk Evaluation and Mitigation Strategies (REMS).That esketamine is dispensed under an FDA-mandated REMS imposing prescriber and pharmacy certification, in-office supervised administration, and a defined post-dose monitoring period..
The patient. Each patient is enrolled under the program and cannot take the medication home; it is given and observed on-site 1Ref 1U.S. Food and Drug Administration (2026).Risk Evaluation and Mitigation Strategies (REMS).That esketamine is dispensed under an FDA-mandated REMS imposing prescriber and pharmacy certification, in-office supervised administration, and a defined post-dose monitoring period..

Esketamine is not the only behavioral-health drug gated this way — clozapine's blood monitoring runs on the same REMS logic, which is why clozapine solo prescribing carries a parallel administrative load. Treat the REMS enrollment as a build step with its own timeline, not a form you complete the week before your first patient.

The observed dosing session: the time and room it costs

The clinical event is not a prescription — it is a supervised session in your office. The patient self-administers under observation, then is monitored for a defined recovery period before being cleared to leave, and cannot drive afterward 1Ref 1U.S. Food and Drug Administration (2026).Risk Evaluation and Mitigation Strategies (REMS).That esketamine is dispensed under an FDA-mandated REMS imposing prescriber and pharmacy certification, in-office supervised administration, and a defined post-dose monitoring period.. Plan on a session measured in hours, a quiet room you can dedicate to it, and a staff member present throughout. That monitored recovery time is the real cost of the service, repeated at every dose.

Twice-weekly induction dosing early in treatment means the same patient occupies that room repeatedly for weeks before the interval stretches out. For a practice of one, the constraint is rarely the drug — it is whether your schedule and your square footage can hold a chair for hours at a time without displacing the visits that pay the rest of your overhead. Staff coverage matters too: someone qualified has to be present for the full monitoring window, not only to hand off the device.

How the visit and the drug get billed

Two things get paid for, and they are billed differently. The encounter itself is an evaluation and management (E/M) service, selected by medical decision making or total time under the 2021-forward framework and documented to that standard 2Ref 2Centers for Medicare & Medicaid Services (2023).Evaluation and Management Services Guide.That the office encounter is billed as an E/M service selected by medical decision making or total time under the 2021-forward framework and documented to that standard.. The drug and its supervised administration are paid separately — and exactly how depends on the payer, so confirm the policy in writing before the first dose.

What is paid	How it is determined
The office encounter	E/M by medical decision making or total time 2Ref 2Centers for Medicare & Medicaid Services (2023).Evaluation and Management Services Guide.That the office encounter is billed as an E/M service selected by medical decision making or total time under the 2021-forward framework and documented to that standard.
The drug supply	The payer's drug-coverage and prior-authorization policy
The supervised administration and observation	The payer's administration/observation policy

Payers structure esketamine payment in one of two shapes: a bundle that folds the drug, its administration, and the observation into a single service line, or the drug billed under its own supply line alongside separate administration and observation charges. Which one applies is set by the payer's published policy, not by you. Verify eligibility and secure the authorization before you schedule the induction series — an unauthorized run of observed doses is an expensive denial to eat as a practice of one.

Buy-and-bill or the certified-pharmacy channel

Because esketamine flows only through a REMS-certified pharmacy 1Ref 1U.S. Food and Drug Administration (2026).Risk Evaluation and Mitigation Strategies (REMS).That esketamine is dispensed under an FDA-mandated REMS imposing prescriber and pharmacy certification, in-office supervised administration, and a defined post-dose monitoring period., the classic buy-and-bill model many practices use for injectables often does not apply in its usual form — the certified pharmacy supplies the product to your site rather than you purchasing and warehousing it. That removes the drug-inventory float, but it also removes the margin some practices count on from acquiring a drug and billing it.

If you do carry any drug on your books elsewhere in the practice — the way lais in a solo practice can be handled through buy-and-bill — remember that drug inventory changes your bookkeeping and touches the expense patterns that sit among common irs audit triggers. Keep the acquisition, the administration, and the observation cleanly separated in your records so each line is defensible on its own, and reconcile what the certified pharmacy shipped against what you administered and billed.

Where telepsychiatry fits — and where it can't

The observed dose is an in-person event by definition: the patient is monitored on-site and cannot drive home afterward 1Ref 1U.S. Food and Drug Administration (2026).Risk Evaluation and Mitigation Strategies (REMS).That esketamine is dispensed under an FDA-mandated REMS imposing prescriber and pharmacy certification, in-office supervised administration, and a defined post-dose monitoring period., so no video visit can substitute for the administration itself. Telepsychiatry still does real work around it — the intake, the between-dose medication management, symptom tracking, and the consent conversation are all defensible over video 3Ref 3American Psychiatric Association (2026).Telepsychiatry Toolkit.That telepsychiatry can carry the intake, between-dose medication management, and consent conversation around an in-person dosing service.. The dosing sessions are the fixed in-person core the rest of the care can orbit.

Bill the video encounters under the telehealth rules that apply to them and keep the in-person administration documented separately; conflating a remote check-in with an on-site observed dose is where telehealth-plus-procedure billing goes wrong. If most of your panel is remote, decide early whether you have the physical space and schedule to run an on-site dosing service at all, because the geography of your patients does not change what the REMS requires.

Does it pencil out for a practice of one?

The decision is operational before it is clinical. Every vendor that touches patient information in this workflow — the REMS enrollment portal, the certified pharmacy's ordering system, your EHR — is a business associate, and each needs a signed business associate agreement before any PHI flows 4Ref 4HHS Office for Civil Rights (2026).Business Associates.That vendors creating, receiving, maintaining, or transmitting PHI in the workflow (REMS portal, pharmacy ordering system, EHR) are business associates requiring a signed BAA.. Add the dedicated room, the staff hours per observed dose, and the prior-authorization work, and the service only earns its place at a predictable patient volume.

Two more paperwork edges are worth naming up front. Self-pay pricing carries obligations of its own that the nsa for office practice addresses. And because two separate money streams — the drug and the observed service — ride on every session, getting the units and the documented observation time right is not just tidy billing; sloppy claims here are exactly the exposure the fca and the solo practice warns about. Run the volume math with your own numbers before you commit the room.

Common questions

No. Under the drug's REMS, esketamine is dispensed only to a certified healthcare setting and self-administered there under direct observation; the patient is monitored on-site before leaving and cannot take doses home. That in-office, supervised structure is the defining operational feature of offering it, and it is what separates esketamine from an ordinary outpatient prescription.

Plan for a session measured in hours, not minutes. After self-administration, the patient is monitored for a defined recovery period before being cleared to leave, and cannot drive afterward. For a solo practice, the binding constraint is usually the room and the staff time each observed dose consumes, especially during the more frequent early-induction schedule, rather than anything about the drug itself.

Esketamine moves through a REMS-certified pharmacy channel, so the usual buy-and-bill pattern of purchasing and stocking a drug often does not apply. The certified pharmacy supplies the product to your certified site. That spares you the inventory float and waste risk, but it also means the acquisition margin some practices rely on with other injectables is generally not available here. Confirm the exact channel with your certified pharmacy.

Four things: your prescriber and site certifications in the REMS, a relationship with a REMS-certified pharmacy, a business associate agreement with every vendor that will touch patient data, and written confirmation of how each payer covers the drug, its administration, and the observation. With those secured, the remaining question is purely operational — whether your schedule and space can hold observed dosing sessions at a workable volume.

Run your practice on Gale

The software is free. Gale earns one flat 3.5% all-in per paid transaction — only on transactions that actually pay. No subscription, no setup fee, no network cut.

Start or manage a practice →

References

1.U.S. Food and Drug Administration (2026). Risk Evaluation and Mitigation Strategies (REMS). U.S. Food and Drug Administration. link ✓That esketamine is dispensed under an FDA-mandated REMS imposing prescriber and pharmacy certification, in-office supervised administration, and a defined post-dose monitoring period.
2.Centers for Medicare & Medicaid Services (2023). Evaluation and Management Services Guide. CMS Medicare Learning Network (MLN006764). link ✓That the office encounter is billed as an E/M service selected by medical decision making or total time under the 2021-forward framework and documented to that standard.
3.American Psychiatric Association (2026). Telepsychiatry Toolkit. American Psychiatric Association. link ✓That telepsychiatry can carry the intake, between-dose medication management, and consent conversation around an in-person dosing service.
4.HHS Office for Civil Rights (2026). Business Associates. U.S. Department of Health and Human Services. linkThat vendors creating, receiving, maintaining, or transmitting PHI in the workflow (REMS portal, pharmacy ordering system, EHR) are business associates requiring a signed BAA.

https://www.gale.care/for-providers/bhp-esketamine-rems-billing · 4 sources. Competitor details are cited to dated public sources and maintained as they change; figures are estimates, not commitments. Synthetic demonstration.

← Back to for providers